Implications of Renal Disease in Patients Undergoing Peripheral Arterial Interventions.
Acute Kidney Injury
/ chemically induced
Aged, 80 and over
Amputation, Surgical
/ statistics & numerical data
Angiography
/ adverse effects
Ankle Brachial Index
/ methods
Contrast Media
/ adverse effects
Early Diagnosis
Endovascular Procedures
/ adverse effects
Humans
Intermittent Claudication
/ diagnosis
Ischemia
/ surgery
Lower Extremity
/ blood supply
Male
Mortality
/ trends
Peripheral Arterial Disease
/ diagnosis
Renal Insufficiency, Chronic
/ complications
Risk Factors
United States
/ epidemiology
Chronic renal disease
Claudication
Critical limb ischemia
Peripheral arterial disease
Peripheral arterial intervention
Journal
Interventional cardiology clinics
ISSN: 2211-7466
Titre abrégé: Interv Cardiol Clin
Pays: Netherlands
ID NLM: 101615153
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
entrez:
31
5
2020
pubmed:
31
5
2020
medline:
7
5
2021
Statut:
ppublish
Résumé
Since the first peripheral endovascular intervention (PVI) in 1964, the procedure's technical aspects and indications have advanced significantly. Today, endovascular procedures span the spectrum of presentations from acute limb ischemia to critical limb ischemia and symptomatic limiting claudication. Goals of PVI remain restoring limb perfusion, minimizing rates of amputation and mortality, and sparing the need for the high-risk bypass surgery. Unfortunately, there are no large randomized controlled trials that address the optimal approach to peripheral arterial disease revascularization in chronic kidney disease (CKD) patients.
Identifiants
pubmed: 32471675
pii: S2211-7458(20)30018-3
doi: 10.1016/j.iccl.2020.02.007
pii:
doi:
Substances chimiques
Contrast Media
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
345-356Informations de copyright
Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Disclosure The authors have nothing to disclose.